JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB96699

Anti-PFKFB3 antibody

Be the first to review this product! Submit a review

|

(10 Publications)

Rabbit Polyclonal PFKFB3 antibody. Suitable for IP, WB, IHC-P and reacts with Human samples. Cited in 10 publications. Immunogen corresponding to Synthetic Peptide within Human PFKFB3 aa 450 to C-terminus.

View Alternative Names

PFK/FBPase 3, Renal carcinoma antigen NY-REN-56, iPFK-2, PFKFB3

3 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PFKFB3 antibody (AB96699)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PFKFB3 antibody (AB96699)

Immunohistochemical analysis of paraffin-embedded bt483 xenograft tissue labelling PFKFB3 protein at nucleus with ab96699 at a 1/500 dilution.
Antigen retrieval : EDTA based, pH 8.0 buffer, 15min

Immunoprecipitation - Anti-PFKFB3 antibody (AB96699)
  • IP

Unknown

Immunoprecipitation - Anti-PFKFB3 antibody (AB96699)

PFKFB3 was immunoprecipitated using 0.5mg A431 whole cell extract, 5µg of Rabbit polyclonal to PFKFB3 and 50µl of protein G magnetic beads (+). No antibody was added to the control (-).
The antibody was incubated under agitation with Protein G beads for 10min, A431 whole cell extract lysate diluted in RIPA buffer was added to each sample and incubated for a further 10min under agitation.
Proteins were eluted by addition of 40µl SDS loading buffer and incubated for 10min at 70oC; 10µl of each sample was separated on a SDS PAGE gel, transferred to a nitrocellulose membrane, blocked with 5% BSA and probed with ab96699.
Secondary : Mouse monoclonal [SB62a] Secondary Antibody to Rabbit IgG light chain (HRP) (ab99697).
Band : 70kDa : PFKFB3.

All lanes:

Immunoprecipitation - Anti-PFKFB3 antibody (ab96699)

Predicted band size: 60 kDa

false

Western blot - Anti-PFKFB3 antibody (AB96699)
  • WB

Supplier Data

Western blot - Anti-PFKFB3 antibody (AB96699)

Samples were separated by 10% SDS-PAGE.

All lanes:

Western blot - Anti-PFKFB3 antibody (ab96699) at 1/1000 dilution

Lane 1:

Jurkat whole cell extracts at 30 µg

Lane 2:

Raji whole cell extracts at 30 µg

Lane 3:

NCI-H929 whole cell extracts at 30 µg

Secondary

All lanes:

HRP-conjugated anti-rabbit IgG antibody

Predicted band size: 60 kDa

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IP, WB, IHC-P

applications

Immunogen

Synthetic Peptide within Human PFKFB3 aa 450 to C-terminus. The exact immunogen used to generate this antibody is proprietary information.

Q16875

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/100 - 1/500", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500 - 1/3000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100 - 1/1000", "IHCP-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
pH: 7 Preservative: 0.01% Thimerosal (merthiolate) Constituents: 10% Glycerol (glycerin, glycerine), 1.21% Tris, 0.75% Glycine
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

PFKFB3 also known as 6-phosphofructo-2-kinase/fructose-26-bisphosphatase 3 serves a significant role in regulating glycolysis. This bifunctional enzyme weighs approximately 58 kDa and manages levels of fructose-26-bisphosphate a potent activator of another enzyme called phosphofructokinase-1. PFKFB3 expression occurs in various tissues but is especially high in areas with active cell proliferation like the brain and tumors. This enzyme's activity affects glycolytic flux critical for energy production and biosynthesis especially under conditions requiring rapid energy supply.
Biological function summary

PFKFB3 regulates cellular energy metabolism serving as a switch for converting carbohydrates into energy and building blocks for growth. This enzyme is part of a glycolytic complex coordinating energy needs during proliferation and survival. Its activity is important in processes demanding increased energy and anabolic precursors such as cell division. The enzyme's modulation affects fructose-26-bisphosphate levels influencing cellular responses to stress and nutrient availability directly impacting metabolic adaptation.

Pathways

PFKFB3 integrates into the glycolytic pathway and the pentose phosphate pathway. PFKFB3's control over fructose-26-bisphosphate levels influences phosphofructokinase-1 modulating the glycolytic pathway's rate. This modulation impacts energy production efficiency and the provision of metabolites required for nucleotide synthesis linking to the pentose phosphate pathway. Proline-rich AKT substrate of 40 kDa (PRAS40) and AKT may also interact indirectly to regulate PFKFB3 activity in these metabolic pathways.

PFKFB3 links strongly to cancer and diabetes. Its upregulation in cancerous tissues supports tumor growth by promoting glycolysis known as the Warburg effect. Cancer-associated proteins such as KRAS often rely on PFKFB3's glycolytic control to sustain proliferative signaling. Additionally in diabetes altered PFKFB3 activity can contribute to insulin resistance due to disrupted metabolic homeostasis with insulin pathway proteins like IRS1 potentially interacting with it in this context.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Catalyzes both the synthesis and degradation of fructose 2,6-bisphosphate.
See full target information PFKFB3

Publications (10)

Recent publications for all applications. Explore the full list and refine your search

Gut 74:1828-1846 PubMed40335161

2025

Microbiota fasting-related changes ameliorate cognitive decline in obesity and boost ex vivo microglial function through the gut-brain axis.

Applications

Unspecified application

Species

Unspecified reactive species

Virginia Mela,Violeta Heras,Monika Iesmantaite,María Luisa García-Martín,Manuel Bernal,Joel D Posligua-García,Alba Subiri-Verdugo,José Ignacio Martínez-Montoro,Ana María Gómez-Pérez,Borja Bandera,Isabel Moreno-Indias,Francisco J Tinahones

Oncology reports 50: PubMed37800625

2023

Unrevealed roles of extracellular enolase‑1 (ENO1) in promoting glycolysis and pro‑cancer activities in multiple myeloma via hypoxia‑inducible factor 1α.

Applications

Unspecified application

Species

Unspecified reactive species

I-Che Chung,Wei-Ching Huang,Yung-Tsang Huang,Mao-Lin Chen,An-Wei Tsai,Pei-Yu Wu,Ta-Tung Yuan

Scientific reports 13:15080 PubMed37699938

2023

Klotho increases antioxidant defenses in astrocytes and ubiquitin-proteasome activity in neurons.

Applications

Unspecified application

Species

Unspecified reactive species

Ana Maria Orellana,Caio Henrique Mazucanti,Leticia Pavan Dos Anjos,Larissa de Sá Lima,Elisa Mitiko Kawamoto,Cristoforo Scavone

Pharmacological research 168:105592 PubMed33813027

2021

In vitro angiogenesis inhibition with selective compounds targeting the key glycolytic enzyme PFKFB3.

Applications

Unspecified application

Species

Unspecified reactive species

Anahita Abdali,Denisa Baci,Isabella Damiani,Federica Belloni,Carlo De Dominicis,Maria Luisa Gelmi,Alberto Corsini,Stefano Bellosta

International journal of oncology 52:945-954 PubMed29393396

2018

PFKFB3 is involved in breast cancer proliferation, migration, invasion and angiogenesis.

Applications

Unspecified application

Species

Unspecified reactive species

Fang Peng,Qiang Li,Jia-Yuan Sun,Ying Luo,Ming Chen,Yong Bao

The EMBO journal 36:3325-3335 PubMed28963395

2017

LncRNA wires up Hippo and Hedgehog signaling to reprogramme glucose metabolism.

Applications

Unspecified application

Species

Unspecified reactive species

Xin Zheng,Han Han,Guang-Ping Liu,Yan-Xiu Ma,Ruo-Lang Pan,Ling-Jie Sang,Rui-Hua Li,Luo-Jia Yang,Jeffrey R Marks,Wenqi Wang,Aifu Lin

Oncoimmunology 5:e1229725 PubMed28123869

2016

Transcriptional and metabolic reprogramming induce an inflammatory phenotype in non-medullary thyroid carcinoma-induced macrophages.

Applications

Unspecified application

Species

Unspecified reactive species

Rob J W Arts,Theo S Plantinga,Sander Tuit,Thomas Ulas,Bas Heinhuis,Marika Tesselaar,Yvette Sloot,Gosse J Adema,Leo A B Joosten,Johannes W A Smit,Mihai G Netea,Joachim L Schultze,Romana T Netea-Maier

Scandinavian journal of medicine & science in sports 26:384-96 PubMed25892654

2015

Strength training improves cycling performance, fractional utilization of VO2max and cycling economy in female cyclists.

Applications

Unspecified application

Species

Unspecified reactive species

O Vikmoen,S Ellefsen,Ø Trøen,I Hollan,M Hanestadhaugen,T Raastad,B R Rønnestad

Molecular and cellular biology 34:3642-61 PubMed25047839

2014

Plk1 phosphorylation of PTEN causes a tumor-promoting metabolic state.

Applications

Unspecified application

Species

Unspecified reactive species

Zhiguo Li,Jie Li,Pengpeng Bi,Ying Lu,Grant Burcham,Bennett D Elzey,Timothy Ratliff,Stephen F Konieczny,Nihal Ahmad,Shihuan Kuang,Xiaoqi Liu

Cell metabolism 17:745-55 PubMed23623748

2013

WNT-LRP5 signaling induces Warburg effect through mTORC2 activation during osteoblast differentiation.

Applications

Unspecified application

Species

Unspecified reactive species

Emel Esen,Jianquan Chen,Courtney M Karner,Adewole L Okunade,Bruce W Patterson,Fanxin Long
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com